Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Pozycja w akcjach #17918
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Cena akcji
$18.20
Ostatnia synchronizacja: 2025-05-09
Kapitalizacja rynkowa
$220.35M
Zmiana (1 dzień)
-5.34%
Zmiana (1 rok)
0.00%
Kraj
JP
Handel I'rom Group Co., Ltd. (2372)

Kategoria

Zyski dla I'rom Group Co., Ltd. (2372)
Zyski w Dec 2024 TTM: $9.98M
Według najnowszych raportów finansowych I'rom Group Co., Ltd., obecny zysk firmy wynosi $9.98M. W roku 2023 firma osiągnęła zysk w wysokości $25.17M, wzrost w porównaniu do zysku z roku 2022, który wynosił $21.24M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy I'rom Group Co., Ltd. od 2005 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$9.87B 98,800.88%
US
- -
DE
$687.82M 6,791.50%
SA
$3.87B 38,624.74%
US
- -
MY